QR Kod

The concordance of treatment decision guided by OncotypeDX and the PREDICT tool in real‐world early‐stage breast cancer

Abstract Background Decision‐making regarding adjuvant chemotherapy for early‐stage breast cancer can be guided by genomic assays such as OncotypeDX. The concordance of expected clinical decisions guided by OncotypeDX and prognostication online tools such as PREDICT is unknown. Methods We performed...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Daniel A. Goldstein, Chen Mayer, Tzippy Shochat, Daniel Reinhorn, Assaf Moore, Michal Sarfaty, Rinat Yerushalmi, Hadar Goldvaser
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Wiley 2020-07-01
Seri Bilgileri:Cancer Medicine
Konular:
Online Erişim:https://doi.org/10.1002/cam4.3088
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!